Degradation of misfolded proteins in neurodegenerative diseases: therapeutic targets and strategies
- PMID: 25766616
- PMCID: PMC4351408
- DOI: 10.1038/emm.2014.117
Degradation of misfolded proteins in neurodegenerative diseases: therapeutic targets and strategies
Abstract
Mammalian cells remove misfolded proteins using various proteolytic systems, including the ubiquitin (Ub)-proteasome system (UPS), chaperone mediated autophagy (CMA) and macroautophagy. The majority of misfolded proteins are degraded by the UPS, in which Ub-conjugated substrates are deubiquitinated, unfolded and cleaved into small peptides when passing through the narrow chamber of the proteasome. The substrates that expose a specific degradation signal, the KFERQ sequence motif, can be delivered to and degraded in lysosomes via the CMA. Aggregation-prone substrates resistant to both the UPS and the CMA can be degraded by macroautophagy, in which cargoes are segregated into autophagosomes before degradation by lysosomal hydrolases. Although most misfolded and aggregated proteins in the human proteome can be degraded by cellular protein quality control, some native and mutant proteins prone to aggregation into β-sheet-enriched oligomers are resistant to all known proteolytic pathways and can thus grow into inclusion bodies or extracellular plaques. The accumulation of protease-resistant misfolded and aggregated proteins is a common mechanism underlying protein misfolding disorders, including neurodegenerative diseases such as Huntington's disease (HD), Alzheimer's disease (AD), Parkinson's disease (PD), prion diseases and Amyotrophic Lateral Sclerosis (ALS). In this review, we provide an overview of the proteolytic pathways in neurons, with an emphasis on the UPS, CMA and macroautophagy, and discuss the role of protein quality control in the degradation of pathogenic proteins in neurodegenerative diseases. Additionally, we examine existing putative therapeutic strategies to efficiently remove cytotoxic proteins from degenerating neurons.
Figures





Similar articles
-
Evidence Linking Protein Misfolding to Quality Control in Progressive Neurodegenerative Diseases.Curr Top Med Chem. 2020;20(23):2025-2043. doi: 10.2174/1568026620666200618114924. Curr Top Med Chem. 2020. PMID: 32552649 Review.
-
Aggregate-prone proteins are cleared from the cytosol by autophagy: therapeutic implications.Curr Top Dev Biol. 2006;76:89-101. doi: 10.1016/S0070-2153(06)76003-3. Curr Top Dev Biol. 2006. PMID: 17118264 Review.
-
Walking the tightrope: proteostasis and neurodegenerative disease.J Neurochem. 2016 May;137(4):489-505. doi: 10.1111/jnc.13575. Epub 2016 Mar 8. J Neurochem. 2016. PMID: 26872075 Review.
-
Protein Quality Control by Molecular Chaperones in Neurodegeneration.Front Neurosci. 2017 Apr 6;11:185. doi: 10.3389/fnins.2017.00185. eCollection 2017. Front Neurosci. 2017. PMID: 28428740 Free PMC article. Review.
-
Molecular chaperone dysfunction in neurodegenerative diseases and effects of curcumin.Biomed Res Int. 2014;2014:495091. doi: 10.1155/2014/495091. Epub 2014 Oct 19. Biomed Res Int. 2014. PMID: 25386560 Free PMC article. Review.
Cited by
-
TTC3-Mediated Protein Quality Control, A Potential Mechanism for Cognitive Impairment.Cell Mol Neurobiol. 2022 Aug;42(6):1659-1669. doi: 10.1007/s10571-021-01060-z. Epub 2021 Feb 27. Cell Mol Neurobiol. 2022. PMID: 33638766 Free PMC article. Review.
-
Autophagy Markers Are Altered in Alzheimer's Disease, Dementia with Lewy Bodies and Frontotemporal Dementia.Int J Mol Sci. 2024 Jan 17;25(2):1125. doi: 10.3390/ijms25021125. Int J Mol Sci. 2024. PMID: 38256197 Free PMC article.
-
Lysosomal Storage Diseases-Regulating Neurodegeneration.J Exp Neurosci. 2016 Apr 5;9(Suppl 2):81-91. doi: 10.4137/JEN.S25475. eCollection 2015. J Exp Neurosci. 2016. PMID: 27081317 Free PMC article. Review.
-
Physical Exercise-Induced Myokines in Neurodegenerative Diseases.Int J Mol Sci. 2021 May 28;22(11):5795. doi: 10.3390/ijms22115795. Int J Mol Sci. 2021. PMID: 34071457 Free PMC article. Review.
-
Neuroprotective Effects of Ginseng Phytochemicals: Recent Perspectives.Molecules. 2019 Aug 14;24(16):2939. doi: 10.3390/molecules24162939. Molecules. 2019. PMID: 31416121 Free PMC article. Review.
References
-
- Ciechanover A. Intracellular protein degradation: from a vague idea through the lysosome and the ubiquitin–proteasome system and onto human diseases and drug targeting. Bioorg Med Chem. 2013;21:3400–3410. - PubMed
-
- Sriram SM, Kim BY, Kwon YT. The N-end rule pathway: emerging functions and molecular principles of substrate recognition. Nat Rev Mol Cell Biol. 2011;12:735–747. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous